Article Details
Retrieved on: 2024-05-07 21:32:57
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses a fatal incident in a Pfizer clinical trial for Duchenne muscular dystrophy gene therapy (fordadistrogene movaparvovec), sparking safety concerns and a partial trial pause for investigation. Relevant tags are clinical research, gene therapy, and Pfizer.
Article found on: www.biopharmadive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here